Literature DB >> 20227636

Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage.

M Guillon1, C Maissa, S Ho.   

Abstract

The objective was to compare the effect on conjunctival tissues of the repeated use, over a one-month period, of Optive compared to Hylocomod eyedrops by a population of dry eye sufferers. The rationale for the study was that among dry eye sufferers who attend eye care practices for symptomatic relief, a large number present with conjunctival anomalies evidenced by tissue staining and that conjunctival recovery is essential to their successful long term management. The hypothesis tested was that the decrease in conjunctival staining with Optive is at least as good, and possibly greater, than that with Hylocomod. The cohort population was made up of 47 subjects (11 male and 26 female) aged 42+/-16 years with at least mild dry eye symptoms and conjunctival and/or corneal staining. The population included contact lens wearers (n=26) and non-wearers (n=21). The subjects were randomly allocated to use one of the two study products; they were instructed to use the products as often as needed but at least three times a day. Conjunctival staining was rated on forced choice scales and measured objectively using digital photographs and image analysis. The findings showed that, whereas the staining at the start of the investigation was similar (p=0.318-0.664), staining after one month of use was significantly less with Optive than Hylocomod (p=0.028-0.002). The results demonstrated that the regular use of Optive over one month was significantly superior to Hylocomod in improving conjunctival status by producing a greater reduction in the staining of dry eye sufferers. 2010 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227636     DOI: 10.1016/j.clae.2010.01.007

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  11 in total

Review 1.  The role and treatment of inflammation in dry eye disease.

Authors:  Ayse Yagci; Canan Gurdal
Journal:  Int Ophthalmol       Date:  2014-07-26       Impact factor: 2.031

2.  Effectiveness of dry eye therapy under conditions of environmental stress.

Authors:  Alan Tomlinson; Louise C Madden; Peter A Simmons
Journal:  Curr Eye Res       Date:  2013-01-07       Impact factor: 2.424

3.  Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.

Authors:  Peter A Simmons; Haixia Liu; Cindy Carlisle-Wilcox; Joseph G Vehige
Journal:  Clin Ophthalmol       Date:  2015-04-15

4.  Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study.

Authors:  Georgios Labiris; Panagiota Ntonti; Haris Sideroudi; Vassilios Kozobolis
Journal:  Eye Vis (Lond)       Date:  2017-05-10

5.  Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.

Authors:  M Labetoulle; F Chiambaretta; A Shirlaw; R Leaback; C Baudouin
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

6.  Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.

Authors:  Philippe Daull; Elisabeth Raymond; Laurence Feraille; Jean-Sébastien Garrigue
Journal:  J Ocul Pharmacol Ther       Date:  2018-10-12       Impact factor: 2.671

7.  Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine.

Authors:  Neeta Khandekar; Mark D P Willcox; Sharon Shih; Peter Simmons; Joseph Vehige; Qian Garrett
Journal:  Mol Vis       Date:  2013-09-19       Impact factor: 2.367

8.  A prospective, multicenter, noninterventional study of Optive Plus(®) in the treatment of patients with dry eye: the prolipid study.

Authors:  Thomas Kaercher; Ulrich Thelen; Gerrett Brief; Robert J Morgan-Warren; Richard Leaback
Journal:  Clin Ophthalmol       Date:  2014-06-17

9.  Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment.

Authors:  Silvia Tampucci; Daniela Monti; Susi Burgalassi; Eleonora Terreni; Erica Zucchetti; Filippo Baldacci; Patrizia Chetoni
Journal:  Pharmaceutics       Date:  2018-08-25       Impact factor: 6.321

10.  Impact of 0.1% sodium hyaluronate and 0.2% sodium hyaluronate artificial tears on postoperative discomfort following cataract extraction surgery: a comparative study.

Authors:  Panagiota Ntonti; Eirini-Kanella Panagiotopoulou; Georgios Karastatiras; Nektarios Breyannis; Sevasti Tsironi; Georgios Labiris
Journal:  Eye Vis (Lond)       Date:  2019-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.